V

VALANX Biotech

10 employees

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

Basic info

Industry

biotechnology research

Sectors

Research and Development
Biotechnology
Health Care
PEGylation
Medical
Bioconjugation
Pharmaceutical
Site-specific conjugation

Date founded

2017

Funding rounds raised

Total raised

$100K

from 6 investors over 6 rounds

V

VALANX Biotech raised undisclosed on December 21, 2021

Investors: SOSV - The Accelerator VC

V

VALANX Biotech raised undisclosed on May 14, 2020

Investors: xista science ventures and SOSV - The Accelerator VC

V

VALANX Biotech raised undisclosed on January 28, 2020

Investors: SOSV - The Accelerator VC

V

VALANX Biotech raised undisclosed on August 17, 2017

Investors: SOSV - The Accelerator VC

V

VALANX Biotech raised $100K on April 5, 2017

Investors: SOSV - The Accelerator VC

FAQ